IHC Reagents and Supplies
Defense Health Agency · DEFENSE HEALTH AGENCY
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HT940727PE002 in this department, oldest first.
- Oct 6, 2026 · this noticeAward NoticeAGILENT TECHNOLOGIES INC · $350K
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
The contract was not awarded competitively in accordance with Revolutionary FAR Overhaul (RFO) 12.102(a) - acquisitions valued at or below the simplified acquisition threshold.
Who won similar work
7 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Defense Health Agency), same product/service code (PSC) 6505.
Single-winner award sizes (7): middle half $634K to $2.1M, median $900K; range $350K to $5.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $5.0M | Jan 29, 2026 |
| CARDINAL HEALTH 414, LLC · $CAH · $226.8B | 1 | $2.4M | Oct 1, 2026 |
| PROLACTA BIOSCIENCE, INC | 1 | $1.9M | Dec 4, 2024 |
| CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 1 | $900K | Aug 12, 2026 |
| KEMP PROTEINS, LLC | 1 | $864K | Jul 11, 2025 |
| INO THERAPEUTICS LLC | 1 | $404K | Mar 12, 2025 |
| BOSTON SCIENTIFIC CORP · $BSX · $14.2B | 1 | $350K | Aug 21, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $CAH reported $226.8B revenue in FY2026. The median single-winner award in these 7 past awards, $900K, is under 0.1% of that. 10-K
- $BSX reported $14.2B revenue in FY2025. The median single-winner award in these 7 past awards, $900K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026CARDINAL HEALTH 414, LLC$2.4MFDA-Approved Radiopharmaceutical Supplies and Cold Kits
- Aug 21, 2026BOSTON SCIENTIFIC CORP$350KY-90 Glass Theraspheres
- Aug 12, 2026CENTRAL ADMIXTURE PHARMACY SERVICES, INC$900KPre-Mixed IV Fluids, cardioplegic solutions, and specialized Total Parenteral Nutrition
- Jan 29, 2026Novartis Pharmaceuticals Corporation$5.0MPluvicto and Lutathera 5 Year BPA
- Jul 11, 2025KEMP PROTEINS, LLC$864KHybridoma Development Studies and Antibody Production
- Mar 12, 2025INO THERAPEUTICS LLC$404KNotice of Intent to Sole Source Neonatal Pediatric Inhaled Nitric Oxide (INO) Gas
- Dec 4, 2024PROLACTA BIOSCIENCE, INC$1.9MPasteurized Human-Based milk
Competitive landscape
For the 7 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (4 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- $60K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Armed Services, Senate Committee on Appropriations, Senate Committee on Armed Services
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 5 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.